Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2012

View Archived Issues

NeoGenomics launches prognostic cancer test in U.S.

Discovery of a novel mineralocorticoid receptor antagonist

Proteome Sciences provides CKI-delta inhibitor portfolio update

Foundation Medicine and Clovis Oncology launch collaboration

Aquapharm discovers antibiotic against multidrug-resistant bacteria

Antisense products show promise in model of myotonic dystrophy

Fate Therapeutics divulges novel Wnt compositions

ACEA Biosciences presents new candidate cancer therapeutics

In vivo studies demonstrate neuroprotective effects of microRNA's silencing

Crystal Biopharmaceutical patents novel camptothecin derivatives

New anticancer microRNA prepared in the Netherlands

Ono Pharmaceutical announces highlights of second quarter 2012

Researchers at Lilly disclose novel kinase inhibitors

Shire reviews accomplishments for second quarter of 2012

Astellas files for approval of orally disintegrating tablet for IBS

NeurogesX provides update on next steps for NGX-1998

Trana identifies new target for development of antibiotics

Antibody targeting Wnt/beta-catenin pathway shows promising anticancer activity

Affinium completes enrollment in phase II trial of oral antibiotic for ABSSSI

New cancer vaccines designed by Oncbiomune

Mylan out-licenses Japanese rights to next-generation epinephrine product

Novel immune deficiency and immune dysregulation phenotype and related gene mutation identified

Recruitment complete in study of rheumatoid arthritis stem cell therapy

Achillion provides update on candidate drugs for genotype 1 HCV infection

AstraZeneca to halt development of CytoFab

OncoGenex kicks off enrollment in AFFINITY study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...